Chicago & Midwest CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
Fulton Market Life Sciences Project Replaced by Apartment Tower Plans
While Fulton Market has been an epicenter of life sciences activity, a Chicago developer is changing course from a previously approved lab project and plans to build a massive apartment project instead.
A venture led by Chicago-based Mark Goodman filed a zoning application for a two-tower, 724-unit apartment complex at 400 N. Elizabeth Street. The move is a pivot from the 16-story lab building on the site that was approved by the city in 2021.
Goodman paid almost $15.8 million for the site in early 2022, and earlier this year, he hired CBRE to market the development site to prospective investors. Per the outlet, high interest rates and a cooling in venture-capital funding for life sciences played into the switch of plans. The area has been a hotbed of life sciences developments such as Trammell Crow’s Fulton Market Labs, which is home to the Chan Zuckerberg Biohub and MonoSol.


